Company intelligence / Profile preview

FluidicLab

Shanghai, Shanghai Municipality, Chinaen.fluidiclab.com ↗

Ownership: Private
Development stage: Commercial

Overview

FluidicLab develops and manufactures advanced microfluidic components and integrated systems used in droplet/micropshere generation, nanoparticle production (including LNPs for mRNA vaccines), organoid-on-chip models, digital PCR workflows, CAR-T cell preparation support equipment, and more. Their solutions enable applications in cell biology research, drug delivery R&D/manufacturing scale-up, single-cell analysis/transcriptomics library construction. They also offer CRO services including barcode bead synthesis and organoid cultivation.

Modalities: Device (microfluidic systems)Nanoparticle (LNP generator)Droplet microfluidics platform (enabling various modalities such as mRNA delivery and single-cell encapsulation)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on FluidicLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FluidicLab.

Explore the full profile